These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36121816)

  • 1. Cumulative incidence, prevalence, seroconversion, and associated factors for SARS-CoV-2 infection among healthcare workers of a University Hospital in Bogotá, Colombia.
    Valderrama-Beltrán SL; Cuervo-Rojas J; Ariza B; Cardozo C; Ángel J; Martinez-Vernaza S; Juliana Soto M; Arcila J; Salgado D; Rondón M; Cepeda M; Castellanos JC; Gómez-Restrepo C; Franco MA
    PLoS One; 2022; 17(9):e0274484. PubMed ID: 36121816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
    Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
    Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.
    Musa S; Abdel Alem S; Amer K; Elnagdy T; Hassan WA; Ali MA; Gaber Y; Badary HA; Tantawi O; Abdelmoniem R; Radwan A; Yousof H; Shawky S; Talaat H; Fouad R; Kassem AM
    J Infect Public Health; 2021 Oct; 14(10):1466-1473. PubMed ID: 34175238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence, infection, and personal protective equipment use among Colombian healthcare workers during the COVID-19 pandemic.
    Beltrán EO; Martignon S; Coronel-Ruiz C; Velandia-Romero ML; Romero-Sanchez C; Avila V; Castellanos JE
    Front Public Health; 2023; 11():1225037. PubMed ID: 37900032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors related to SARS-CoV-2 infection, reinfection, and seroconversion: Analysis of a healthcare workers cohort from a university hospital in Colombia.
    Nieto MA; Caballero N; Remolina CI; Moreno S; Vega D; Quintero J
    IJID Reg; 2023 Dec; 9():63-71. PubMed ID: 37928802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
    Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
    BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study.
    Brousseau N; Morin L; Ouakki M; Savard P; Quach C; Longtin Y; Cheng MP; Carignan A; Dufresne SF; Leduc JM; Lavallée C; Gauthier N; Bestman-Smith J; Arrieta MJ; Ishak M; Lévesque S; Martin P; De Serres G
    CMAJ; 2021 Dec; 193(49):E1868-E1877. PubMed ID: 34903591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and disease incidence in German healthcare workers before and during the rollout of COVID-19 vaccines.
    Gehring S; Kowalzik F; Okasha O; Engelmann T; Schreiner D; Jensen C; Mähringer-Kunz A; Hartig-Merkel W; Mai Phuong Tran T; Oostvogels C; Verstraeten T
    PLoS One; 2024; 19(1):e0294025. PubMed ID: 38289913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Longitudinal Serosurvey of Healthcare Workers in the First Wave of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic in a Quaternary Care Hospital in Munich, Germany.
    Weinberger T; Steffen J; Osterman A; Mueller TT; Muenchhoff M; Wratil PR; Graf A; Krebs S; Quartucci C; Spaeth PM; Grabein B; Adorjan K; Blum H; Keppler OT; Klein M
    Clin Infect Dis; 2021 Nov; 73(9):e3055-e3065. PubMed ID: 33388756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 infection and seroconversion rates in healthcare workers in Lebanon: An observational study.
    Helou M; Zoghbi S; El Osta N; Mina J; Mokhbat J; Husni R
    Medicine (Baltimore); 2023 Apr; 102(17):e32992. PubMed ID: 37115042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Antibodies to SARS-CoV-2 Following Natural Infection and Vaccination in Irish Hospital Healthcare Workers: Changing Epidemiology as the Pandemic Progresses.
    Allen N; Brady M; Ni Riain U; Conlon N; Domegan L; Carrion Martin AI; Walsh C; Doherty L; Higgins E; Kerr C; Bergin C; Fleming C
    Front Med (Lausanne); 2021; 8():758118. PubMed ID: 35186963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of SARS-CoV-2 infection and SARS-CoV-2-specific antibody detection among healthcare workers and hospital staff of a university hospital in Colombia.
    Caballero N; Nieto MA; Suarez-Zamora DA; Moreno S; Remolina CI; Durán D; Vega D; Rodríguez-Urrego PA; Gómez CP; Rojas DP; Ramírez A; Martínez O; Baldión-Elorza AM; Hernández LJ; Quintero J
    IJID Reg; 2022 Jun; 3():150-156. PubMed ID: 35720138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care.
    Klevebro S; Bahram F; Elfström KM; Hellberg U; Hober S; Merid SK; Kull I; Nilsson P; Tornvall P; Wang G; Conneryd Lundgren K; Ponzer S; Dillner J; Melén E
    Scand J Public Health; 2021 Nov; 49(7):707-712. PubMed ID: 34148454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-COV-2 seroprevalence among all healthcare workers in a tertiary hospital in Spain.
    Cantero M; Millán-Pérez R; Muñez E; Gómez-Lozano N; Anel-Pedroche J; Parra LM; Rodríguez ML; Asensio A
    Infect Dis (Lond); 2022 Jan; 54(1):8-15. PubMed ID: 34424122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
    Hori H; Fukuchi T; Sanui M; Moriya T; Sugawara H
    PLoS One; 2021; 16(10):e0257513. PubMed ID: 34634076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
    Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
    J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.
    Papasavas P; Olugbile S; Wu U; Robinson K; Roberts AL; O'Sullivan DM; McLaughlin T; Mather JF; Steinberg AC; Orlando R; Kumar A
    J Hosp Infect; 2021 Aug; 114():117-125. PubMed ID: 33930487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care Workers.
    Sikkens JJ; Buis DTP; Peters EJG; Dekker M; Schinkel M; Reijnders TDY; Schuurman AR; de Brabander J; Lavell AHA; Maas JJ; Koopsen J; Han AX; Russell CA; Schinkel J; Jonges M; Matamoros S; Jurriaans S; van Mansfeld R; Wiersinga WJ; Smulders YM; de Jong MD; Bomers MK
    JAMA Netw Open; 2021 Jul; 4(7):e2118554. PubMed ID: 34319354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
    Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
    BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests.
    van Dam P; Huizing M; Roelant E; Hotterbeekx A; De Winter FHR; Kumar-Singh S; Moons P; Amajoud Z; Vulsteke C; Croes L; Janssens A; Berneman Z; Prenen H; Meuris L; Vanden Berghe W; Smits E; Peeters M
    Eur J Cancer; 2021 May; 148():328-339. PubMed ID: 33773276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.